SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is trending following a positive earnings report that highlighted a surge in collectibles sales and record operating income, alongside significant insider buying by a board member. While some traders view these developments as bullish, discussion remains polarized with skeptics pointing to declining core revenue, the absence of an earnings call, and concerns regarding future dilution.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple shares experienced significant volatility following the launch of the new iPhone 18 Pro series and the company's first foldable smartphone, the 'iPhone Duo.' While many in the community expressed excitement over the new hardware, traders remain divided on the device's high price point and whether the launch represents true innovation or a delayed response to competitors.

SK hynix, Inc. engages in the design, manufacture, and sale of semiconductor products. Its products include dynamic random access memory, not-AND flash memory, and multi-chip package. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is trending following a Bank of America upgrade to Buy with a $250 price target, driven by surging AI demand for memory chips and the company's strong positioning in the high-bandwidth memory market. While the community sentiment is generally bullish due to the company's solid market leadership, some traders are expressing uncertainty and initiating short positions, citing concerns over volatility and the potential for profit-taking in a crowded trade.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy shares trended downward following a second-quarter report that featured a modest sales beat and raised full-year outlook, which were ultimately overshadowed by stagnant gross margins and declining free cash flow. While some traders focused on the raised guidance as a long-term positive, the immediate market reaction was negative, with many expressing frustration over the stock's persistent price decline.

Opus Genetics, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Durham, NC.

Opus Genetics Inc.

Opus Genetics (IRD) surged after the company announced that its VEGA-3 Phase 3 clinical trial for phentolamine ophthalmic solution successfully met its primary endpoint for treating presbyopia. Community discussion remains highly bullish, with many traders viewing the trial success as a de-risked setup and speculating on significant potential upside, though some remain concerned about the company's history of capital raises.

Norwegian Cruise Line Holdings Ltd. engages in the provision of cruise travel services. It offers cruise experiences for travelers with itineraries in Europe, Asia, Australia, New Zealand, South America, Africa, Canada, Bermuda, Caribbean, Alaska and Hawaii. Its brands include Norwegian Cruise Line, Oceania Cruises, and Regent Seven Seas Cruises. The company was founded in 1966 and is headquartered in Miami, FL.

Norwegian Cruise Line Holdings Ltd

NCLH is trending as traders express frustration over the stock's failure to rally despite recent declines in oil prices, a key factor for cruise line profitability. While some investors see the current price as a buying opportunity given recent insider accumulation and positive earnings, others are skeptical due to concerns over high debt, market manipulation, and the impact of broader geopolitical tensions on operating costs.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is trending as the community anticipates the company's upcoming second-quarter earnings report, with investors focusing on the status of its rolling NDA submission and commercialization readiness for COMP360. Discussions are further driven by recent positive trial data updates, ongoing hiring efforts, and strategic partnerships, leading traders to discuss the company's long-term potential in the treatment-resistant depression market.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment shares are seeing significant volatility as traders debate the company's valuation and guidance following a strong quarterly earnings report that featured record revenue and a record backlog. While the community is split between bullish sentiment over contract wins and bearish concerns regarding profitability and price suppression, investors remain focused on the company's long-term potential in the defense drone sector.

Oddity Tech Ltd. engages in the online retail sale of cosmetics and beauty products. Its products include lipsticks, makeup brushes, mascara, eyelash curlers, and makeup brush cleansers. The company was founded by Oran Holtzman and Shiran Holtzman-Erel on March 23, 2013 and is headquartered in Tel Aviv, Israel.

ODDITY Tech Ltd. - Ordinary Shares - Class A

ODDITY Tech shares experienced significant volatility and a steep decline following Q1 revenue guidance that fell below expectations due to an advertising account disruption. While the community is debating whether the stock is undervalued given its cash position and potential for operational recovery, sentiment remains divided between those viewing the pullback as a buying opportunity and those concerned about the company's long-term advertising strategy.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks shares are experiencing pressure as traders debate the long-term impact of its AI-driven cost-cutting strategy and broader consumer discretionary trends. While some investors remain bullish on the turnaround efforts under new leadership, others express concern over softening consumer demand and increased competition from lower-cost coffee alternatives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BML Capital Management LLC Sells 858,613 Shares of Connect Biopharma Holdings Limited Sponsored ADR $CNTB

BML Capital Management LLC lowered its holdings in shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) by 67.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owne...

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB) Given Average Rating of "Moderate Buy" by Analysts

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the five research firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating, three have assig...

Northland Securities Weighs in on CNTB Q1 Earnings

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Equities research analysts at Northland Securities issued their Q1 2026 earnings per share (EPS) estimates for Connect...

Q1 Earnings Estimate for CNTB Issued By HC Wainwright

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Free Report) - Stock analysts at HC Wainwright issued their Q1 2026 earnings estimates for shares of Connect Biopharma in a research note issued on Wednesday, April 8th. HC Wainwright analyst B. Folkes expects that the company will post...

Shares of Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) have earned a consensus recommendation of "Moderate Buy" from the five ratings firms that are currently...

Connect Biopharma (NASDAQ:CNTB) Director Buys $4,002,000.00 in Stock

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang acquired 1,160,000 shares of Connect Biopharma stock in a transaction that occurred on Tuesday...

Connect Biopharma (NASDAQ:CNTB) Director James Huang Acquires 1,160,000 Shares

Connect Biopharma Holdings Limited Sponsored ADR (NASDAQ:CNTB - Get Free Report) Director James Huang bought 1,160,000 shares of the stock in a transaction on Tuesday, March 31st. The stock was purchased at an average cost of $3.45 per share, with a total value of $4,002,000.00. Following the...

Connect Biopharma (NASDAQ:CNTB) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS

Connect Biopharma (NASDAQ:CNTB - Get Free Report) posted its earnings results on Tuesday. The company reported ($0.27) earnings per share for the quarter, topping analysts' consensus estimates of...

Connect Biopharma (NASDAQ:CNTB) Receives "Buy" Rating from BTIG Research

BTIG Research restated a "buy" rating and issued a $10.00 price target on shares of Connect Biopharma in a research report on Tuesday...

Connect Biopharma touts rapid IV rademikibart FEV1 gains; Phase 3 atopic dermatitis data impresses

Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha monoclonal antibody, highlighting preliminary top-line results from an intravenous...

Connect Biopharma Holdings Ltd. operates as clinical-stage biopharmaceutical company. It focuses on advancing rademikibart, an anti-interleukin-4-receptor alpha antibody, to transform acute and chronic care in asthma and chronic obstructive pulmonary disease. The company was founded by Zheng Wei and Wu Bin Pan on November 23, 2015 and is headquartered in San Diego, CA.

Connect Biopharma Holdings Ltd

Bullish Sentiment

Yes, day one

Yes, but I'll wait for reviews

No, too expensive

No, not interested in a foldable

Apple unveiled its first foldable iPhone, reportedly called the iPhone Duo, at its September 9 event, with pricing starting at $2,000 for the 256GB model. Will you buy the $2,000 iPhone Duo? Vote and explain your reasoning in the comments.

Apple ($AAPL) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Stocktwits

) just unveiled its first foldable iPhone, the iPhone Duo, starting at $2,000. Will you buy it?

Feed

News

Sentiment

Fundamentals

Info

CNTB Connect Biopharma Holdings Ltd

Fundamentals

Latest CNTB News